We will provide an overview of how drug-drug and drug-food interactions (DDIs) can impact the clinical course of an individual undergoing behavioral health or substance use disorder treatment and explore the benefits and limitations of various tools and practices available to clinicians to identify and treat DDIs. Attendees will have an opportunity to review data from urine and oral fluid samples to understand how interacting substances can be identified in an objective manner and see how the data is used to work through and resolve medication-related problems.
Describe examples of common DDIs in the behavioral health and substance use disorder clinical settings and the clinical effects of the interactions.
List commonly utilized tools to identify DDIs in routine clinical practice and potential limitations of those tools.
Explain objective identification of recently ingested substances in urine and oral fluid and how this can be utilized in conjunction with medication adherence monitoring to evaluate select individuals for DDIs.